Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naive Metastatic Clear-Cell Renal Cell Carcinoma

DSpace Repository

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naive Metastatic Clear-Cell Renal Cell Carcinoma

Author: Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; Giles, Rachel H.; Hora, Milan; Lam, Thomas B.; Ljungberg, Borje; Marconi, Lorenzo; Klatte, Tobias; Volpe, Alessandro; Abu-Ghanem, Yasmin; Dabestani, Saeed; Fernandez-Pello, Sergio; Hofmann, Fabian; Kuusk, Teele; Tahbaz, Rana; Powles, Thomas; Bex, Axel
Tübinger Autor(en):
Bedke, Jens
Published in: European Urology (2021), Bd. 79, H. 3, S. 339-342
Verlagsangabe: Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.eururo.2020.12.005
ISSN: 1873-7560
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)